// App-Quantinova.ai

M2113 2015 AHA : Clinical Implementation of CYP2C19-genotype Guided Antiplatelet Therapy Reduces Cardiovascular Events After PCI

Researchers

Presenter

  • Oyunbileg Magvanjav

Principal Investigators

  • R.David Anderson

  • Petr Starostik

  • Rhonda M Cooper-DeHoff

  • Kristin W Weitzel

  • Michael J Clare-Salzler

  • David R Nelson

  • Julie A Johnson

  • Yan Gong

  • Aniwaa Owusu-Obeng

  • Ben Kong

  • Teresa Vo

  • Jennifer N Ashton

  • Benjamin J Staley

  • Amanda R Elsey

  • Robert W Allan

Medical Centers

  • University of Florida, Cainsvillle, FL

  • Oregon State University, Corvallis, OR

  • Univ of FL Coll Pharmacy, Gainesville, FL

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • University of South Florida, Tampa, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Venous thrombosis

  • Stroke

Biomarkers

  • Fas receptor

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

  • Prasugrel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved